dr. yelena janjigian on the matterhorn study: durvalumab plus flot in gastric cancer at asco gi 2024
Published 8 months ago • 244 plays • Length 5:18Download video MP4
Download video MP3
Similar videos
-
1:00:39
stomach cancer q&a with yelena janjigian, m.d., chief of gastrointestinal oncology
-
2:00
matterhorn: neoadjuvant-adjuvant durvalumab and flot chemotherapy in resectable g/gej
-
4:42
conquering cancer with yelena janjigian, md and david solit, md
-
1:24
dr. janjigian on the javelin gastric 100 study with avelumab in gastric/gej cancer
-
2:08
dr. yelena janjigian discusses #checkmate649 & #attraction4 presented at #esmo20 stomach oesophagus
-
26:51
gastro journal club: antireflux treatment and risk of esophageal adenocarcinoma
-
1:16
【黄夷伍：早期胰腺癌可以根治】9/25 #时事大家谈 #精彩点评
-
20:36
difference between neuroendocrine and adenocarcinoma pancreatic cancers
-
1:00
dr. janjigian on conducting msi testing in gastric cancer
-
21:36
understanding, detecting, and treating gastroesophageal junction adenocarcinoma
-
1:54
dr. janjigian on updated results from the destiny-gastric01 trial in her2 gastric cancer
-
2:07
dr. janjigian on immunotherapy combinations in gastric cancer
-
26:00
novel frontiers of the gastric microbiome - 2022 gastric cancer summit
-
1:47
dr. janjigian on immunotherapy in esophageal and gastric cancer
-
3:18
gastric cancer treatment and research highlights
-
2:18
how can gastric cancer patients insist on better care?
-
2:00
dr. janjigian on pembrolizumab triplet in her2 esophagogastric cancer
-
1:03
novel treatments for gastric cancer
-
3:01
factors to consider when choosing a gastric cancer treatment approach
-
3:11
zanidatamab investigated for her2 advanced or metastatic gastro-oesophageal adenocarcinoma
-
2:09
recent advances in gastrointestinal research: destiny-gastric01 and spotlight